InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Peterson Richard d, 首席财务官. Director active across 3 companies, notably Clarus Therapeutics Holdings, Inc.. In total, 9 filings have been recorded. Split: 1 buy · 2 sells. Total volume traded: €123k. Activity tracked since 11 December 2021. The latest transaction was disclosed on 30 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Peterson Richard d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
2,000 股@ US$34.1035100.0% 占其流量Common StockSEC:0000891166-26-000031:0
1,855 股@ US$33.6142.8% 占其流量Common StockSEC:0001430423-25-000003:0
2,824 股0Common StockSEC:0000891166-25-000137:0
2,404 股0Common StockSEC:0000891166-25-000102:0
3,491 股@ US$18.6285.6% 占其流量Common StockSEC:0000891166-24-000047:0
4,005 股0Common StockSEC:0000891166-23-000074:0
1,075 股@ US$9.30514.4% 占其流量Common StockSEC:0000891166-22-000105:0
标准退出：2022年12月28日 (T+90)
5,337 股0Common StockSEC:0000891166-22-000078:0
55,800 股0Common StockSEC:0000899243-21-048204:0
9 条申报中的 9 条
About Peterson Richard d
PETERSON RICHARD D is Directeur Financier. He is also listed as Director at UNIVERSAL INSURANCE HOLDINGS, INC. and Universal Insurance Holdings, INC., and as Chief Financial Officer at Clarus Therapeutics Holdings, Inc. He has 9 filings in total, and in the sampled recent filings the amounts shown run from 2021-12-14 to 2026-03-31, with 10176 in buys and 112475 in sells.
